EMA-ISCT Bilateral Meeting

About the EMA-ISCT Bilateral Meeting

The EMA-ISCT Bilateral Meeting serves as a forum for open dialogue between regulators and stakeholders across the cell and gene therapy sector. Through scientific exchange and discussion of regulatory priorities, the meeting supports greater alignment, knowledge sharing, and understanding of developments affecting the translation of advanced therapies from research to patient access.

This member resource page provides access to presentation materials, speaker information, and key topics discussed during the meeting. The content reflects expert perspectives from both regulatory and stakeholder communities on issues shaping the future of advanced therapy medicinal products (ATMPs) in Europe and globally.

The meeting was organized and led by the ISCT Europe Industry Committee and the ISCT Europe Legal & Regulatory Affairs Committee (Europe LRA), reinforcing ISCT's mission to facilitate meaningful engagement between regulators and the cell and gene therapy field.

Inaugural Meeting (2026)

On October 5, 2026, EMA hosted the inaugural EMA-ISCT bilateral meeting, bringing together over 20 representatives from EMA and ISCT for scientific and regulatory exchange on topics of importance to the cell and gene therapy field.

Topics and Presentations

Clinical Trial Regulation for ATMPs

Boundaries of Minimal Manipulation

Monographs for Cell and Gene Therapies

Log in to your ISCT Member Account to access the presentations.

Not an ISCT Member? Fill out this form to view the presentations.